BR0307122A - nucleic acid encoding a protein-coupled receptor and its uses - Google Patents
nucleic acid encoding a protein-coupled receptor and its usesInfo
- Publication number
- BR0307122A BR0307122A BR0307122-7A BR0307122A BR0307122A BR 0307122 A BR0307122 A BR 0307122A BR 0307122 A BR0307122 A BR 0307122A BR 0307122 A BR0307122 A BR 0307122A
- Authority
- BR
- Brazil
- Prior art keywords
- protein
- nucleic acid
- acid encoding
- coupled receptor
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Vascular Medicine (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
"áCIDO NUCLéICO CODIFICANDO UM RECEPTOR ACOPLADO à PROTEìNA G E SEUS USOS". A presente invenção refere-se a um receptor acoplado à proteína G útil que está envolvido na transdução de sinal com relação à inflamação e resposta imunológica fisiológica. São também providos métodos de uso do receptor para avaliar moléculas que podem modular a atividade do receptor. Tais moléculas podem imediatamente ter aplicações no tratamento de uma pletora de inflamação e doenças e distúrbios imunologicamente relacionados."NUCLEIC ACID ENCODING A RECEIVER COUPLED WITH PROTEIN G AND ITS USES". The present invention relates to a useful G-protein coupled receptor that is involved in signal transduction with respect to inflammation and physiological immune response. Methods of using the receptor to evaluate molecules that can modulate receptor activity are also provided. Such molecules may immediately have applications in the treatment of a plethora of inflammation and immunologically related diseases and disorders.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35100602P | 2002-01-23 | 2002-01-23 | |
GBGB0210597.1A GB0210597D0 (en) | 2002-01-23 | 2002-05-09 | A nucleic acid encoding a G-protein-coupled receptor,and uses thereof |
PCT/US2003/001694 WO2003061365A2 (en) | 2002-01-23 | 2003-01-21 | A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0307122A true BR0307122A (en) | 2004-12-28 |
Family
ID=27614811
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0307122-7A Withdrawn BR0307122A (en) | 2002-01-23 | 2003-01-21 | nucleic acid encoding a protein-coupled receptor and its uses |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1470420A4 (en) |
JP (1) | JP2005514934A (en) |
BR (1) | BR0307122A (en) |
CA (1) | CA2473707A1 (en) |
MX (1) | MXPA04007117A (en) |
NO (1) | NO20043123L (en) |
RU (1) | RU2004125608A (en) |
WO (1) | WO2003061365A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004083388A2 (en) | 2003-03-14 | 2004-09-30 | Bristol-Myers Squibb Company | Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1575601A (en) * | 1999-10-27 | 2001-05-08 | Pharmacia & Upjohn Company | G protein-coupled receptors expressed in brain |
IL149569A0 (en) * | 1999-11-17 | 2002-11-10 | Arena Pharm Inc | Endogenous and non-endogenous versions of human g protein-coupled receptors |
WO2001094385A2 (en) * | 2000-06-05 | 2001-12-13 | Bayer Aktiengesellschaft | Human hm74-like g protein coupled receptor |
-
2003
- 2003-01-21 RU RU2004125608/15A patent/RU2004125608A/en not_active Application Discontinuation
- 2003-01-21 CA CA002473707A patent/CA2473707A1/en not_active Abandoned
- 2003-01-21 WO PCT/US2003/001694 patent/WO2003061365A2/en not_active Application Discontinuation
- 2003-01-21 JP JP2003561321A patent/JP2005514934A/en active Pending
- 2003-01-21 EP EP03710699A patent/EP1470420A4/en not_active Withdrawn
- 2003-01-21 BR BR0307122-7A patent/BR0307122A/en not_active Withdrawn
- 2003-01-21 MX MXPA04007117A patent/MXPA04007117A/en unknown
-
2004
- 2004-07-20 NO NO20043123A patent/NO20043123L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MXPA04007117A (en) | 2005-02-25 |
RU2004125608A (en) | 2005-04-20 |
WO2003061365A3 (en) | 2003-11-13 |
NO20043123L (en) | 2004-07-20 |
EP1470420A4 (en) | 2005-08-24 |
JP2005514934A (en) | 2005-05-26 |
WO2003061365A2 (en) | 2003-07-31 |
CA2473707A1 (en) | 2003-07-31 |
EP1470420A2 (en) | 2004-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Moulin et al. | Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells | |
Krueger et al. | Peptidoglycans as promoters of slow-wave sleep. II. Somnogenic and pyrogenic activities of some naturally occurring muramyl peptides; correlations with mass spectrometric structure determination. | |
Proost et al. | Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation | |
Peng et al. | Interleukin-6 protects cultured cerebellar granule neurons against glutamate-induced neurotoxicity | |
Petes et al. | Interleukin (IL)-6 inhibits IL-27-and IL-30-mediated inflammatory responses in human monocytes | |
ATE442385T1 (en) | INTERLEUKIN-17 RECEPTOR-LIKE PROTEIN | |
BRPI0410741A (en) | immunosuppressive compound and compositions | |
BRPI0407401A (en) | bicyclic compounds and compositions | |
ATE182901T1 (en) | DNA CODING FOR ANDROGEN RECEPTOR PROTEIN | |
Okazaki et al. | Synergistic activation of c-fos promoter activity by Raf and Ral GDP dissociation stimulator | |
ATE233813T1 (en) | MODIFIED IMMUNOLOBULINS FOR SPECIFIC FC-EPSILON RECEPTORS | |
PT910647E (en) | Human dnase i hyperactive variants | |
Xu et al. | The potential role of mechanically sensitive ion channels in the physiology, injury, and repair of articular cartilage | |
DE69636437D1 (en) | LIGAND POLYPEPTIDE FOR HYPOPHYSE G PROTEIN COUPLED RECEPTOR PROTEIN, THEIR PREPARATION AND APPLICATION | |
BR9811093A (en) | Pyridines replaced with 2-amino-6- (2-substituted 4-phenoxy) | |
BR0316923A (en) | Mitoneet polypeptide of mitochondrial membranes, their modulators and methods for their use | |
ATE290080T1 (en) | HUMAN BETA-9 CHEMOKINE | |
Klatt et al. | Matrilin-3 activates the expression of osteoarthritis-associated genes in primary human chondrocytes | |
Naruishi et al. | Impairment of gingival fibroblast adherence by IL-6/sIL-6R | |
BR9807085A (en) | Il-8 receptor antagonists | |
Saviano et al. | New biologic (Ab-IPL-IL-17) for IL-17-mediated diseases: identification of the bioactive sequence (nIL-17) for IL-17A/F function | |
BR0307122A (en) | nucleic acid encoding a protein-coupled receptor and its uses | |
BR0307707A (en) | nucleic acid encoding a g-protein coupled receptor and using it | |
DE69131133D1 (en) | USE OF GRO GENES AND PROTEINS | |
EE03483B1 (en) | 4-Amino-tetrahydro-benzisoxazole or isothiazole compounds, their use in the preparation of pharmaceutical preparations and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE A 4O, 5O, 6O E 7O ANUIDADE. |
|
B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2047 DE 30/03/2010. |